Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361).

MLA

Smolinski, Michael P., et al. “Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361).” Journal of Medicinal Chemistry, vol. 61, no. 11, June 2018, pp. 4704–19. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.8b00164.

APA

Smolinski, M. P., Bu, Y., Clements, J., Gelman, I. H., Hegab, T., Cutler, D. L., Fang, J. W. S., Fetterly, G., Kwan, R., Barnett, A., Lau, J. Y. N., & Hangauer, D. G. (2018). Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361). Journal of Medicinal Chemistry, 61(11), 4704–4719. https://doi.org/10.1021/acs.jmedchem.8b00164

Chicago

Smolinski, Michael P, Yahao Bu, James Clements, Irwin H Gelman, Taher Hegab, David L Cutler, Jane W S Fang, et al. 2018. “Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361).” Journal of Medicinal Chemistry 61 (11): 4704–19. doi:10.1021/acs.jmedchem.8b00164.